Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENDP
3751
CALL
DELISTED
Endo International plc
ENDP
| $115K | ﹤0.01% |
24,500
| – | – |
|
3752
Team
TISI
$79.5M
| $114K | ﹤0.01% |
1,723
-2,046
| -54% | -$186K |
|
3753
Compañía de Cervecerías Unidas
CCU
$2.11B
| $113K | ﹤0.01% |
5,627
-2,003
| -26% | -$37.2K |
|
3754
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.16B
| $113K | ﹤0.01% |
+2,923
| New | +$115K |
|
3755
CALL
Steel Dynamics
STLD
$36.7B
| $113K | ﹤0.01% |
1,900
| – | – |
|
|
SRT
3756
DELISTED
Startek Inc.
SRT
| $113K | ﹤0.01% |
15,816
-12,341
| -44% | -$90.8K |
|
|
CARM
3757
DELISTED
Carisma Therapeutics
CARM
| $112K | ﹤0.01% |
1,210
-6,322
| -84% | -$403K |
|
3758
IDT Corp
IDT
$1.65B
| $112K | ﹤0.01% |
3,051
-13,520
| -82% | -$384K |
|
3759
iShares Core S&P US Value ETF
IUSV
$27.3B
| $112K | ﹤0.01% |
+1,561
| New | +$112K |
|
3760
Liberty Latin America Class A
LILA
$1.68B
| $112K | ﹤0.01% |
11,750
-45,072
| -79% | -$428K |
|
3761
Metropolitan Bank Holding Corp
MCB
$1.16B
| $112K | ﹤0.01% |
1,846
-4,006
| -68% | -$244K |
|
3762
Corbus Pharmaceuticals
CRBP
$164M
| $111K | ﹤0.01% |
2,033
-108
| -5% | -$5.99K |
|
3763
OrthoPediatrics
KIDS
$538M
| $111K | ﹤0.01% |
1,751
-9,210
| -84% | -$529K |
|
3764
Transmedics
TMDX
$2.81B
| $110K | ﹤0.01% |
3,333
-17,686
| -84% | -$490K |
|
3765
Energy Fuels
UUUU
$3.01B
| $110K | ﹤0.01% |
18,213
-93,239
| -84% | -$572K |
|
|
ARTY
3766
iShares Future AI & Tech ETF
ARTY
$3.6B
| $110K | ﹤0.01% |
+2,441
| New | +$105K |
|
3767
Descartes Systems
DSGX
$6.56B
| $109K | ﹤0.01% |
1,583
-1,489
| -48% | -$94.1K |
|
3768
Gossamer Bio
GOSS
$82.4M
| $109K | ﹤0.01% |
13,429
+12,942
| +2,657% | +$112K |
|
3769
i3 Verticals
IIIV
$417M
| $109K | ﹤0.01% |
3,617
-12,421
| -77% | -$394K |
|
3770
Flexsteel Industries
FLXS
$315M
| $108K | ﹤0.01% |
2,685
-4,750
| -64% | -$207K |
|
3771
CALL
VanEck Junior Gold Miners ETF
GDXJ
$7B
| $108K | ﹤0.01% |
2,300
| – | – |
|
3772
Modine Manufacturing
MOD
$10.5B
| $108K | ﹤0.01% |
6,516
-44,590
| -87% | -$730K |
|
3773
ProShares UltraPro Russell2000
URTY
$333M
| $108K | ﹤0.01% |
924
+738
| +397% | +$81.8K |
|
3774
PUT
Ventas
VTR
$47.3B
| $108K | ﹤0.01% |
1,900
| – | – |
|
3775
ALPS O'Shares Global Internet Giants ETF
OGIG
$107M
| $107K | ﹤0.01% |
+1,867
| New | +$100K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.